Overexpression of the insulin-like growth factor I receptor in human colon carcinomas

Cancer

Volumn 95, Issue 10, 2002, Pages 2086-2095

  Weber, Matthias M ^a,d   Fottner, Christian ^a   Liu, Sun Bin ^b   Jung, M Christina ^b   Engelhardt, Dieter ^b   Baretton, Gustavo B ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Colon carcinoma; IGF I; IGF I receptor; IGF II; IGFBP

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; AUTOCRINE EFFECT; BINDING SITE; CARCINOMA CELL; COLON ADENOCARCINOMA; COLON CARCINOMA; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; PARACRINE SIGNALING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0037110602     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10945     Document Type: Article

References (49)

1. Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol. 2000;183:1-9.
2. Baserga R. The contradictions of the insulin-like growth factor 1 receptor. Oncogene. 2000;19:5574-5581.
3. LeRoith D. Insulin-like growth factors and cancer. Ann Intern Med. 1995;122:54-59.
4. Ferry RJ Jr., Cerri RW, Cohen P. Insulin-like growth factor binding proteins: New proteins, new functions. Horm Res. 1999;51:53-67.
5. Singh P, Rubin N. Insulin-like growth factors and binding proteins in colon cancer. Gastroenterology. 1993;105:1218-1237.
6. Bustin SA, Jenkins PJ. The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med. 2001;7:447-454.
7. Ma J, Pollak M, Giovannucci E, et al. A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res. 2000;Suppl A:28-29.
8. Townsend CM, Singh P, Thompson JC. Effects of gastrointestinal peptides on gastrointestinal cancer growth. Gastroenterol Clin North Am. 1989;18:777-791.
9. Lahm H, Svardet L, Laurent PL, et al. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor α. Br J Cancer. 1992;65:341-346.
10. Akagi Y, Liu W, Zebrowski B, Xie K, Ellis LM. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res. 1998; 58:4008-4014.
11. Wong BCY, Michell NP, Lewis AE, Watters D, Langman MJS, Eggo Mc. IGF-I rescues colonic cells from apoptosis induced by protein kinase C activators and indomethacin [abstract]. 79th Annual Meeting of the Endocrine Society, Minneapolis, 1997:P1-195.
12. Lambert S, Vivario J, Bonviver J, Gol-Winkler R. Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. Int J Cancer. 1990;46:405-410.
13. Lambert S, Collette J, Gillis J, Franchimont P, Desaive C, Gol-Winkler R. Tumor IGF-II content in a patient with colon adenocarcinoma correlates with abnormal expression of the gene. Int J Cancer. 1991;48:826-830.
14. Tricoli JV, Rall LB, Karakousis CP, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res. 1986;46:6169-6173.
15. Singh P, Dai B, Given RL, Lu X, Holthuizen PE. Differential activation of IGF-II promoters p3 and p4 in caco-2 cells during growth and differentiation. Gastroenterology. 1998; 114:1221-1229.
16. El Atiq F, Garrouste F, Remacle-Bonnet M, Sastre B, Pommier G. Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer. Int J Cancer. 1994;57:491-497.
17. Michell NP, Langman MJS, Eggo MC. Insulin-like growth factors and their binding proteins in human colonocytes: Preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. Br J Cancer. 1997;76:60-66.
18. Guo YS, Narayan S, Yallampalli C, Singh P. Characterization of insulin-like growth factor I receptors in human colon cancer. Gastroenterology. 1992;102:1101-1198.
19. Rouyer-Fessard C, Gammeltoft S, Laburthe M. Expression of two types of receptor for insulin-like growth factors in human colonic epithelium. Gastroenterology. 1990;98:703-707.
20. Remacle-Bonnet MM, Culouscou JM, Garrouste FL, Rabenandrasana C, Marvaldi JL, Pommier GJ. Expression of type 1, but not type II insulin-like growth factor receptors on both undifferentiated and differentiated HT29 human colon carcinoma cell line. J Clin Endocrinol Metab. 1992;75:609-616.
21. Zenilman ME, Graham W. Insulin-like growth factor I receptor messenger RNA in the colon is unchanged during neoplasia. Cancer Invest. 1997;15:1-7.
22. Adenis A, Peyrat JP, Hecquet B, et al. Type I insulin-like growth factor receptors in human colorectal cancer. Eur J Cancer. 1995;31A:50-55.
23. Mishra L, Bass B, Ooi BS, Sidaway A, Korman L. Role of insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding protein-2 in human colorectal cancers. Growth Horm IGF Res. 1998;8:473-479.
24. Freier S, Weiss O, Eran M, et al. Expression of the insulinlike growth factors and their receptors in adenocarcinoma of the colon. Gut. 1999;44:704-708.
25. Hakam A, Yeatman J, Lu L, et al. Expression of insulin-like growth factor-1 receptors in human colorectal cancer. Hum Pathol. 1999;30:1128-1133.
26. Jass JR, Sobin LH. Histological Typing of Intestinal Tumors. World Health Organization. International Classification of Tumors. New York: Springer, 1989.
27. Zhang W, Thorton WH, MacDonald RS. Insulin-like growth factor-I and II receptor expression in rat colon mucosa are affected by dietary lipid intake. J Nutr. 1998;182:158-165.
28. Kutoh E, Boss O, Levasseur M, Giacobino JP. Quantification of the full length leptin receptor (OB-Rb) in human brown and white adipose tissue. Life Sci. 1998;62:445-451.
29. Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA. 1990;87:2725-2729.
30. Alms WJ, Braun-Elwert L, James SP, Yurovsky VV, White B. Simultaneous quantitation of cytokine mRNAs by reverse transcription-polymerase chain reaction using multiple internal standard cRNAs. Diagn Mol Pathol. 1996;5:88-97.
31. Ullrich A, Gray A, Tam AW, et al. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specifity. EMBO J. 1986;5:2503-2512.
32. Bell GI, Merryweather JP, Sanchez-Pescador R, et al. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature. 1984;310:775-777.
33. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
34. Weber MM, Auernhammer CJ, Kiess W, Engelhardt D. Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands. Eur J Endocrinol. 1997; 136:296-303.
35. Scatchard G. The attraction of proteins for small molecules and ions. Ann N Y Acad Sci. 1949;51:660-672.
36. Remacle-Bonnet M, Garrouste F, El Atiq F, Marvaldi J, Pommier G. Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. J Clin Invest. 1995;96:192-200.
37. Kawamoto K, Onodera H, Kan S, Kondo S, Imamura M. Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma. Cancer. 1999;85:18-25.
38. Hoeflich A, Yan Y, Kessler U, Heinz-Erian P, Kolb H, Kiess W. Human colon carcinoma cells (CaCo2) synthesize IGF-II and express IGF-I receptors and IGF-II/M6P receptors. Mol Cell Endocrinol. 1994;101:141-150.
39. Kawamoto K, Onodera H, Kondo S, et al. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: Correlation with tumor progression, proliferative activity and survival. Oncology. 1998;55:242-248.
40. Hassan AB, Howell JA. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice. Cancer Res. 2000;60:1070-1076.
41. Kaleko M, Rutter WJ, Miller AD. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol. 1990; 10:464-473.
42. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res. 1995; 55:3739-3741.
43. Long L, Nip J, Brodt P. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: A regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res. 1994;54:3732-3737.
44. Hoeflich A, Yang Y, Rascher W, et al. Coordinate expression of insulin-like growth factor II (IGF-II) and IGF-II/mannose6-phosphate receptor mRNA and stable expression of IGF-I receptor mRNA during differentiation of human colon carcinoma cells (caco-2). Eur J Endocrinol. 1996;135:49-59.
45. Lamonerie T, Lavialle C, De Galle B, Binoux M, Brison O. Constituitve or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line. Exp Cell Res. 1995;216:342-351.
46. Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La CA. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci U S A. 2001;98:591-596.
47. Winkler R, Delacroix L, Bensbaho K, Lambert S, Collette J, Hodzic D. IGF-II in primary human colorectal tumors: Peptide level, activated promoters, parental imprinting and gene rearrangement. Horm Metab Res. 1999;31:148-154.
48. Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med. 1998;4:1276-1280.
49. Werner H, Le Roith D. New concepts in regulation and function of the insulin-like growth factors: Implications for understanding normal growth and neoplasia. Cell Mol Life Sci. 2000;57:932-942.